Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

European Lung Cancer Congress 2022: Industry Sponsored Satellite Symposia

ELCC-2022-1000x250

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Tailoring Therapy: Emerging Treatment Options in NSCLC

01-Tailoring-Therapy-Emerging-Treatment-Options-in-NSCLC-MIRATI-Thumb

Wednesday, 11:30 – 13:00
View the satellite invitation

Targeting KRASG12C: A New Era for Patients with Advanced NSCLC

02-Targeting-KRASG12C-A-New-Era-for-Patients-With-Advanced-NSCLC-AMGEN-Thumbnails

Wednesday, 11:30 – 13:00
View the satellite invitation

Breaking Barriers in Thoracic Cancers: The Expanding Possibilities for Patients With I-O Treatment

03-Breaking-Barriers-in-Thoracic-Cancers-BMS-Thumb

Wednesday, 18:15 – 19:45
View the satellite invitation

Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and Implications

04-Novel-Therapies-for-EGFR-Exon-20-Insertions-and-ALK-Positive-NSCLC-TAKEDA-Thumb

Wednesday, 18:15 – 19:45
View the satellite invitation

Evolving Treatment Options and Practices in EGFR-Mutant NSCLC

07-Spotlight-on-Emerging-Therapies-for-Patients-with-EGFR-positive-NSCLC-JANSSEN-Thumb

Thursday, 13:30 – 15:00
View the satellite invitation

CNS Disease Management in EGFRm NSCLC

07-CNS-Disease-Management-in-EGFRm-NSCLC-ASTRAZENECA-Thumb

Thursday, 13:30 – 15:00
View the satellite invitation

Management of Patients with Oncogene-Driven NSCLC: The Shift Towards Personalized Medicine

08-Management-of-Patients-with-METex14-NSCLC-The-Shift-Towards-Personalized-Medicine-NOVARTIS-Thumb

Thursday, 18:15 – 19:45
View the satellite invitation

Enabling Future Improvements in Cancer Care With Fast Next-Generation Sequencing (NGS) Results

09-Enabling-Future-Improvements-in-Cancer-Care-With-Fast-Next-Generation-Sequencing-NGS-Results-THERMO-FISHER-Thumb

Thursday, 18:15 – 19:45
View the satellite invitation

Unresectable Stage III NSCLC: No Patients Left Behind

10-Unresectable-Stage-III-NSCLC-No-Patients-Left-Behind-ASTRAZENECA-Thumb

Friday, 12:45 – 14:15
View the satellite invitation

TTFields: A Potential Innovative Treatment Modality in Lung Cancer

11-TTFields-A-Potential-Innovative-Treatment-Modality-in-Lung-Cancer-NOVOCURE-Thumb

Friday, 12:45 – 14:15
View the satellite invitation

Quantity Versus Quality of Life in Advanced NSCLC Patients Treated with Immunotherapy

12-Quantity-Versus-Quality-of-Life-in-Advanced-NSCLC-Patients-Treated-With-Immunotherapy-SANOFI-Thumb

Friday, 18:45 – 20:15
View the satellite invitation

Evolving Immuno-Oncology Treatment Paradigm in NSCLC

13-Evolving-Immuno-Oncology-Treatment-Paradigm-in-NSCLC-MSD-Thumb

Friday, 18:45 – 20:15
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.